DK117835B - Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf. - Google Patents
Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf.Info
- Publication number
- DK117835B DK117835B DK643865AA DK643865A DK117835B DK 117835 B DK117835 B DK 117835B DK 643865A A DK643865A A DK 643865AA DK 643865 A DK643865 A DK 643865A DK 117835 B DK117835 B DK 117835B
- Authority
- DK
- Denmark
- Prior art keywords
- pyrimidinyl
- salts
- preparation
- therapeutically effective
- acid compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1616164A CH451945A (de) | 1964-12-15 | 1964-12-15 | Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK117835B true DK117835B (da) | 1970-06-08 |
Family
ID=4414930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK643865AA DK117835B (da) | 1964-12-15 | 1965-12-15 | Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3361749A (no) |
| AT (1) | AT256854B (no) |
| BE (1) | BE673707A (no) |
| BR (1) | BR6575691D0 (no) |
| CH (1) | CH451945A (no) |
| DE (1) | DE1545978A1 (no) |
| DK (1) | DK117835B (no) |
| ES (1) | ES320729A1 (no) |
| FI (1) | FI45048C (no) |
| FR (2) | FR1469035A (no) |
| GB (1) | GB1132244A (no) |
| IL (1) | IL24797A (no) |
| NL (2) | NL6516326A (no) |
| NO (1) | NO117424B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH448083A (de) * | 1963-05-04 | 1967-12-15 | Ciba Geigy | Verwendung von neuen Hydroxyaryl-pyrimidinen bei Verfahren zum Schützen von nicht-textilen organischen Materialien |
| CA2406562C (en) * | 2000-05-08 | 2009-09-15 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting pyrimidines and triazines |
| GB0206215D0 (en) * | 2002-03-15 | 2002-05-01 | Novartis Ag | Organic compounds |
| GB0305929D0 (en) * | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
| EP2287156B1 (en) | 2003-08-15 | 2013-05-29 | Novartis AG | 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| WO2007048064A2 (en) * | 2005-10-21 | 2007-04-26 | Exelixis, Inc. | Amino-pyrimidines as casein kinase ii (ck2) modulators |
| ES2559528T3 (es) | 2006-12-08 | 2016-02-12 | Novartis Ag | Compuestos y composiciones como inhibidores de proteína cinasa |
| LU92852B1 (en) * | 2015-10-20 | 2017-05-02 | Athanasios Spathis | NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB971307A (en) * | 1961-03-02 | 1964-09-30 | Wellcome Found | 5-anilinopyrimidines |
-
0
- NL NL129020D patent/NL129020C/xx active
-
1964
- 1964-12-15 CH CH1616164A patent/CH451945A/de unknown
-
1965
- 1965-12-13 US US513597A patent/US3361749A/en not_active Expired - Lifetime
- 1965-12-14 FI FI653001A patent/FI45048C/fi active
- 1965-12-14 NO NO160909A patent/NO117424B/no unknown
- 1965-12-14 DE DE19651545978 patent/DE1545978A1/de active Pending
- 1965-12-14 IL IL24797A patent/IL24797A/en unknown
- 1965-12-14 AT AT1123965A patent/AT256854B/de active
- 1965-12-14 BE BE673707D patent/BE673707A/xx unknown
- 1965-12-14 ES ES0320729A patent/ES320729A1/es not_active Expired
- 1965-12-15 FR FR42328A patent/FR1469035A/fr not_active Expired
- 1965-12-15 DK DK643865AA patent/DK117835B/da unknown
- 1965-12-15 FR FR42331A patent/FR5213M/fr not_active Expired
- 1965-12-15 BR BR175691/65A patent/BR6575691D0/pt unknown
- 1965-12-15 NL NL6516326A patent/NL6516326A/xx unknown
- 1965-12-16 GB GB53540/65A patent/GB1132244A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE673707A (no) | 1966-04-01 |
| FR5213M (no) | 1967-07-03 |
| NL129020C (no) | |
| ES320729A1 (es) | 1966-05-16 |
| FI45048B (no) | 1971-11-30 |
| CH451945A (de) | 1968-05-15 |
| GB1132244A (en) | 1968-10-30 |
| NL6516326A (no) | 1966-06-16 |
| BR6575691D0 (pt) | 1973-09-06 |
| AT256854B (de) | 1967-09-11 |
| IL24797A (en) | 1969-11-12 |
| US3361749A (en) | 1968-01-02 |
| FI45048C (fi) | 1972-03-10 |
| DE1545978A1 (de) | 1969-12-11 |
| FR1469035A (fr) | 1967-02-10 |
| NO117424B (no) | 1969-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK113295B (da) | Fremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. | |
| DK107288C (da) | Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf. | |
| DK114618B (da) | Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf. | |
| DK126592B (da) | Analogifremgangsmåde til fremstilling af substituerede 2-anilinopyridiner eller syreadditionssalte deraf. | |
| DK117835B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf. | |
| DK109869C (da) | Fremgangsmåde til fremstilling af basisk substituerede 2-oxo-benzimidazoliner eller syreadditionssalte deraf. | |
| DK122327B (da) | Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf. | |
| DK119501B (da) | Fremgangsmåde til fremstilling af substituerede malonsyremonohydrazider eller salte deraf. | |
| DK113150B (da) | Fremgangsmåde til fremstilling af 1-isopropylamino-2-hydroxy-3-(o-alkoxymethyl-phenoxy)-propaner eller salte deraf. | |
| DK124827B (da) | Analogifremgangsmåde til fremstilling af carboxyacylaminopenicilliner eller salte deraf. | |
| DK106335C (da) | Fremgangsmåde til fremstilling af derivater af 16-hydroxymethylenyohimbanforbindelser eller syreadditionssalte deraf. | |
| DK115842B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. | |
| DK115703B (da) | Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf. | |
| DK112524B (da) | Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf. | |
| DK129936B (da) | Fremgangsmåde til fremstilling af lincomycinforbindelser eller syreadditionssalte deraf. | |
| DK121375B (da) | Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf. | |
| DK109600C (da) | Fremgangsmåde til fremstilling af 4-p-aminobenzensulfonylamidopyrimidiner eller salte deraf. | |
| DK116213B (da) | Fremgangsmåde til fremstilling af dibenzocycloheptenylestre eller syreadditionssalte heraf. | |
| DK123021B (da) | Analogifremgangsmåde til fremstilling af syreadditionssalte af 2-aminoadamantan. | |
| DK134010B (da) | Analogifremgangsmåde til fremstilling af dibenzocykloheptenforbindelser eller syreadditionssalte deraf. | |
| DK112030B (da) | Fremgangsmåde til fremstilling af 3-amino-1-adamantancarboxylsyre eller salte deraf. | |
| DK115181B (da) | Fremgangsmåde til fremstilling af xylitolnicotinater eller syreadditionssalte deraf. | |
| DK113643B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme piperidinderivater eller syreadditionssalte af disse forbindelser. | |
| DK106437C (da) | Fremgangsmåde til fremstilling af ethylthiolincosaminid eller syreadditionssalte deraf. | |
| DK115255B (da) | Fremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf. |